Clinical trial
Transplantation for Patients With Chronic Lymphocytic Leukemia
NCT00186303 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00186303 |
|---|---|
| Title | Transplantation for Patients With Chronic Lymphocytic Leukemia |
| Official title | Autologous and Allogeneic Peripheral Blood Progenitor (PBPC) Transplantation for Patients With Chronic Lymphocytic Leukemia |
| Lead sponsor | Stanford University, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Leukemia, Lymphocytic, Chronic |
| Intervention type | Procedure |
| Interventions | high dose chemotherapy then autologous hematopoietic cell transplant, ablative allogeneic hematopoietic cell transplant |
| Enrollment | 28 |
| Start date | Nov 1, 1996 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Sep 16, 2005 |
| Last update posted | Dec 17, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: